drugset / Trial / NCT07189455
Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
The main objective is to compare ZG006 with Investigator-Selected Chemotherapy on prolonging overall survival (OS).
Timeline
- Start
- 2025-12-12
- Primary completion
- 2028-10
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Topotecan | Small molecule | — | — |
| Subject | ZG006 | Unknown | 10 mg | Intravenous |